• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of hepcidin expression in renal failure-participation of erythropoiesis related factor-

Research Project

Project/Area Number 20590966
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKanazawa Medical University

Principal Investigator

TOMOSUGI Naohisa  Kanazawa Medical University, 付置研究所, 教授 (80155580)

Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywordsヘプシジン-25 / 骨髄造血機能 / 骨髄造血由来因子
Research Abstract

In this study, serum hepcidin-25, which is the regulator of the iron-metabolism, has been measured by mass spectrometry, and has became a molecular biomarker of erythropoietic disorders including renal anemia、iron overload and inflammation. The characteristics of iron-metabolism are to recycle iron in the closed system without an active iron-excretion system, and to keep the concentration of the serum iron. This is managed with the feed back mechanism based on the transferring receptor2-hepcidin-ferroportin system.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (45 results)

All 2010 2009 2008

All Journal Article (29 results) (of which Peer Reviewed: 26 results) Presentation (16 results)

  • [Journal Article] Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis.2010

    • Author(s)
      Hayashi H, Piperno A, Tomosugi N, Hayashi K, Kimura F, Wakusawa S, Yano M, Tatsumi Y, Hattori A, Pelucchi S, Katano Y, Goto H.
    • Journal Title

      Intern Med. 49(22)

      Pages: 2371-7

    • NAID

      130000413363

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.2010

    • Author(s)
      Kono S, Yoshida K, Tomosugi N, Terada T, Hamaya Y, Kanaoka S, Miyajima H.
    • Journal Title

      Biochim Biophys Acta. 1802(11)

      Pages: 968-75

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Downregulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman's disease (MCD).2010

    • Author(s)
      Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K.
    • Journal Title

      Blood. 116(18)

      Pages: 3627-34

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.2010

    • Author(s)
      Kaneko Y, Miyajima H, Piperno A, Tomosugi N, Hayashi H, Morotomi N, Tsuchida KI, Ikeda T, Ishikawa A, Ota Y, Wakusawa S, Yoshioka K, Kono S, Pelucchi S, Hattori A, Tatsumi Y, Okada T, Yamagishi M.
    • Journal Title

      J Gastroenterol. 45(11)

      Pages: 1163-71

    • NAID

      10027699891

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Increased Hepcidin Production Impairs Iron Metabolism after Pancreatoduodenectomy.2010

    • Author(s)
      Kosuge T, Sawada T, Shimoda M, Kita J, Tomosugi N, Kubota K.
    • Journal Title

      World J Surg. 34(10)

      Pages: 2452-6

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.2010

    • Author(s)
      Hashizume M, Uchiyama Y, Horai N, Tomosugi N, Mihara M.
    • Journal Title

      Rheumatol Int. 30

      Pages: 917-923

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis.2010

    • Author(s)
      Hayashi H
    • Journal Title

      Intern Med

      Volume: 49 Pages: 2371-2377

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.2010

    • Author(s)
      Kono S
    • Journal Title

      Biochim Biophys Acta

      Volume: 1802 Pages: 968-975

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Downregulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman's disease (MCD).2010

    • Author(s)
      Song SN
    • Journal Title

      Blood

      Volume: 116 Pages: 3627-3634

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.2010

    • Author(s)
      Kaneko Y
    • Journal Title

      J Gastroenterol

      Volume: 45 Pages: 1163-1171

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Increased Hepcidin Production Impairs Iron Metabolism after Pancreato duodenectomy.2010

    • Author(s)
      Kosuge T
    • Journal Title

      World J Surg

      Volume: 34 Pages: 2452-2456

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.2010

    • Author(s)
      Hashizume M
    • Journal Title

      Rheumatol Int

      Volume: 30 Pages: 917-923

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 鉄代謝の臨床 鉄欠乏と鉄過剰 診断と治療の進歩-ヘプシジンの発見とその後の発展-2010

    • Author(s)
      友杉直久
    • Journal Title

      日本内科学会雑誌

      Volume: 99 Pages: 1180-1187

    • Related Report
      2010 Annual Research Report
  • [Journal Article] 鉄過剰症 その病態と治療 ヘプシジン測定2010

    • Author(s)
      友杉直久
    • Journal Title

      日本医師会雑誌

      Volume: 139 Pages: 290-290

    • Related Report
      2010 Annual Research Report
  • [Journal Article] Results of the first international round robin for the quantification of urinary and plasma hepcidin assays : need for standardization.2009

    • Author(s)
      Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW.
    • Journal Title

      Haematologica. 94

      Pages: 1748-1752

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.2009

    • Author(s)
      Kanda J, Uchiyama T, Tomosugi N, Higuchi M, Uchiyama T, Kawabata H.
    • Journal Title

      Int J Hematol. 90

      Pages: 545-552

    • NAID

      10026109746

    • Related Report
      2010 Final Research Report
  • [Journal Article] Results of the first international round robin for the quantification of urinary and plasma hepcidin assays : need for stand ardization.2009

    • Author(s)
      Kroot JJ
    • Journal Title

      Haematologica 94

      Pages: 1748-1752

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma.2009

    • Author(s)
      Kamai T
    • Journal Title

      BMC Cancer. 9

      Pages: 270-270

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.2009

    • Author(s)
      Hashizume M
    • Journal Title

      Rheumatol Int 30

      Pages: 917-923

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.2009

    • Author(s)
      Kanda J
    • Journal Title

      Int J Hematol 90

      Pages: 545-552

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.2009

    • Author(s)
      Kanda J
    • Journal Title

      Biol Blood Marrow Transplant. 15

      Pages: 956-962

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum hepcidin-20 is elevated during the acute phase of myocardial infarction.2009

    • Author(s)
      Suzuki H
    • Journal Title

      Tohoku J Exp Med 218

      Pages: 93-98

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.2009

    • Author(s)
      Matsumoto M
    • Journal Title

      Circ J 74

      Pages: 301-306

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C.2009

    • Author(s)
      Sugimoto R
    • Journal Title

      Hepatol Res 39

      Pages: 619-624

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation.2008

    • Author(s)
      Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, Uchiyama T.
    • Journal Title

      Haematologica. 93(10)

      Pages: 1550-4

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.2008

    • Author(s)
      Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, Iwasa M, Kobayashi Y, Hayashi H, Kaito M, Takei Y.
    • Journal Title

      J Hepatol. 49(5)

      Pages: 702-10

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation.2008

    • Author(s)
      Kanda J
    • Journal Title

      Haematologica 93

      Pages: 1550-1554

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma.2008

    • Author(s)
      Kijima H
    • Journal Title

      BMC Cancer. 8

      Pages: 167-167

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.2008

    • Author(s)
      Fujita N
    • Journal Title

      J Hepatol 49

      Pages: 702-710

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] 腎性貧血ガイドライン達成を目指す貧血管理 ヘプシジン-25による新しい観点2010

    • Author(s)
      友杉直久
    • Organizer
      第55回日本透析医学会学術集会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      2010-06-18
    • Related Report
      2010 Annual Research Report
  • [Presentation] 腎性貧血ガイドライン達成を目指す貧血管理ヘプシジン-25による新しい観点2010

    • Author(s)
      友杉直久
    • Organizer
      第54回日本透析医学会学術集会
    • Place of Presentation
      神戸国際会議場
    • Related Report
      2010 Final Research Report
  • [Presentation] 保存期CKD患者における腎性貧血に与える血清インドキシル硫酸の影響の横断的検討2010

    • Author(s)
      勝二達也,友杉直久,植畑拓也,川端裕彰,新畑覚也,坂口悠介,下村明弘,鈴木朗,金子哲也,椿原美治
    • Organizer
      第53回日本腎臓学会学術総会
    • Place of Presentation
      神戸国際会議場
    • Related Report
      2010 Final Research Report
  • [Presentation] Hepcidin-22 produced in urinary space2009

    • Author(s)
      Tomosugi N
    • Organizer
      The 10th International Symposium on Sjogren's Syndrome
    • Place of Presentation
      ブレスト(フランス)
    • Year and Date
      2009-10-01
    • Related Report
      2009 Annual Research Report
  • [Presentation] Hepcidin-22 produced in urinary space2009

    • Author(s)
      Tomosugi N
    • Organizer
      The 8th HUPO World Congress
    • Place of Presentation
      トロント(カナダ)
    • Year and Date
      2009-09-28
    • Related Report
      2009 Annual Research Report
  • [Presentation] シンポジウム12 透析患者における貧血-発症メカニズムと病態-ヘプシジン-25と骨髄造血機能2009

    • Author(s)
      友杉直久
    • Organizer
      第54回日本透析医学会学術集会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      2009-06-07
    • Related Report
      2009 Annual Research Report
  • [Presentation] Elevation of serum hepcidin 25 levels is well correlated with the progression of renal anemia in the peritoneal dialysis patients.2009

    • Author(s)
      Okubo K, Higuchi M, Kamijo Y, Nagasawa M, Tamura K, Tomosugi N
    • Organizer
      ASN Renal Week 2009
    • Place of Presentation
      San Diego, CA
    • Related Report
      2010 Final Research Report
  • [Presentation] TfR2-related hereditary hemochro-matosis in Japan.2009

    • Author(s)
      Mizumoto C, Kanda J, Kawabata H, Uchiyama T, Kojima K, Hayashi T, Hirata M, Nakao K, Tsuchida K, Kawanaka M, Yamada G, Tomosugi N, Tatsumi Y, Hattori A, Hayashi H.
    • Organizer
      2009 International Biolron Society
    • Place of Presentation
      Porto, Portugal
    • Related Report
      2010 Final Research Report
  • [Presentation] 透析患者における貧血 発症メカニズムと病態 ヘプシジン-25と骨髄造血機能2009

    • Author(s)
      友杉直久
    • Organizer
      第54回日本透析医学会学術集会
    • Place of Presentation
      横浜
    • Related Report
      2010 Final Research Report
  • [Presentation] Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation2008

    • Author(s)
      Junya Kanda, Chisaki Mizumoto, Hiroshi Kawabata, Tatsuo Ichinohe, Hideyuki Tsuchida, Tomosugi N, Keitaro Matsuo, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama.
    • Organizer
      50^<th> ASH Annual Meeting
    • Place of Presentation
      San Francisco, CA
    • Related Report
      2010 Final Research Report
  • [Presentation] Results of the First International Round Robin for the Quantification of Urinary and Plasma Hepcidin : Need for Standardization2008

    • Author(s)
      Joyce JC Kroot, Erwin HJM Kemna, Sukhvinder Bansal, Mark Busbridge, Vatascia Campostrini, Domenico Girelli, Robert C Hider, Vasiliki Koliaraki, Avgi Mamalaki, Gordana Olbina, Naohisa Tomosugi, Chris Tselepis, Douglas G Ward, Tomas Ganz, Jan CM Hendriks, Dorine W. Swinkels.
    • Organizer
      50^<th> ASH Annual Meeting
    • Place of Presentation
      San Francisco, CA
    • Related Report
      2010 Final Research Report
  • [Presentation] Identification and quantification of tear proteins in Sjogren's syndrome.2008

    • Author(s)
      Tomosugi N, H.Tuchida, M.Higuchi, H.Sasaki, K.Kitagawa.
    • Organizer
      HUP02008 7th World Congeress
    • Place of Presentation
      Amsterdam, NL
    • Related Report
      2010 Final Research Report
  • [Presentation] 保存期腎不全患者におけるヘプシジンの検討2008

    • Author(s)
      植畑拓也、友杉直久,坂口悠介,下村明弘,井上和則,金子哲也,勝二達也,岡田倫之,椿原美治
    • Organizer
      第51回日本腎臓学会学術総会
    • Place of Presentation
      福岡
    • Related Report
      2010 Final Research Report
  • [Presentation] C型慢性肝炎にみられる鉄過剰状態へのhepcidinの関与2008

    • Author(s)
      藤田尚己,杉本龍亮,本西哲,田中淳一朗,別府徹也,浦和尚史,田中秀明,山本憲彦,小林由直,岩佐元雄,白木克哉,友杉直久,林久男,竹井謙之
    • Organizer
      第94回日本消化器病学会総会
    • Place of Presentation
      福岡国際会議場
    • Related Report
      2010 Final Research Report
  • [Presentation] Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation.2008

    • Author(s)
      J Kanda
    • Organizer
      ASH Annual Meeting
    • Place of Presentation
      サンフランシスコ
    • Related Report
      2008 Annual Research Report
  • [Presentation] Results of the First International Round Robin for the Quantification of Urinary and Plasma Hepcidin : Need for Standardization.2008

    • Author(s)
      JJC Kroot
    • Organizer
      ASH Annual Meeting
    • Place of Presentation
      サンフランシスコ
    • Related Report
      2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi